Elicio Therapeutics Inc COM

Elicio Therapeutics Inc COM is a security (CUSIP 28657F103) tracked across SEC portfolio filings. 51 institutional managers reported $30.3M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $189K via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 51 managers by value.

ManagerLocationValueShares
Knoll Capital Management, LLCMiami, FL$6.7M630,915
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$4.0M70,804
VANGUARD GROUP INCValley Forge, PA$4.0M496,901
Balyasny Asset Management L.P.Chicago, IL$2.6M244,814
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$1.4M135,164
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$1.3M121,631
JANE STREET GROUP, LLCNEW YORK, NY$1.2M
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$992K92,762
CITADEL ADVISORS LLCMIAMI, FL$835K15,978
MARSHALL WACE, LLPLONDON, X0$797K74,512
NORTHERN TRUST CORPCHICAGO, IL$639K59,734
GOLDMAN SACHS GROUP INCNEW YORK, NY$618K57,818
683 Capital Management, LLCNEW YORK, NY$603K56,442
STATE STREET CORPBOSTON, MA$541K50,620
BlackRock, Inc.New York, NY$541K50,597

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Fidelity Series Total Market Index FundFidelity Concord Street Trust$190K0.02%
Guggenheim Active Allocation FundGuggenheim Active Allocation Fund$1370.00%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$-1K-0.00%

More